$ Value
$0
Shares
4,800
Price
$0
Filed
Aug 18
Insider
Name
Podlesak Dennis
Title
—
CIK
0001314595
Roles
Transaction Details
Transaction Date
2025-08-15
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person solely covering equity grants with expiration dates prior to August 21, 2025. Following the sales reported in this Form 4, the Reporting Person has a total of 135,000 options to purchase shares of common stock that are vested and immediately exercisable and no unvested options to purchase shares of common stock. | The sale prices ranged from $13.30 to $14.80. | The sale prices ranged from $14.88 to $15.91. | The sale prices ranged from $15.61 to $16.00. | This option is fully vested.
Filing Info
Podlesak Dennis's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-04 | SNDX | A | $0 |
| 2025-08-18 | SNDX | M | $138K |
| 2025-08-18 | SNDX | ▼ | $304K |
| 2025-08-18 | SNDX | M | $0 |
| 2025-08-15 | SNDX | M | $138K |
| 2025-08-15 | SNDX | ▼ | $298K |
| 2025-08-15 | SNDX | M | $0 |
| 2025-08-15 | SNDX | M | $0 |
| 2025-08-14 | SNDX | M | $138K |
| 2025-08-14 | SNDX | ▼ | $273K |
Other Insiders at SNDX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Podlesak Dennis | — | — | 2026-02-04 |
| Katkin Keith | — | — | 2026-02-04 |
| Legault Pierre | — | — | 2026-02-04 |
|
Goldan Keith A.
Chief Financial Officer
|
— | $115K | 2026-02-09 |
|
Metzger Michael A
Chief Executive Officer
|
— | $514K | 2026-02-09 |
| Huber Martin H. Jr. | — | — | 2026-02-04 |
| Jarrett Jennifer | — | — | 2026-02-04 |
| Rizo Aleksandra | — | — | 2026-02-04 |
|
Botwood Nicholas A.J.
Head of R&D, CMO
|
— | — | 2026-02-04 |